The Valley Desk

ArticleProstate cancer and prostatic diseasesPublished

Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Villanova University. Affiliation source

Publication record

Type
Article
Venue
Prostate cancer and prostatic diseases
Published
Subject terms
Humans; Neoplasm Metastasis; Disease Progression; Benzamides; Nitriles; Phenylthiohydantoin; Prostate-Specific Antigen; Antineoplastic Agents, Hormonal; Prognosis; Survival Rate; Retrospective Studies; Follow-Up Studies
PubMed ID
37935879
Added to directory
Source checked

Report a correction or request removal